Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 60/100

Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Thursday, July 31, 2025 1 min read
Key Takeaway: Elutia Inc. has announced that it will release its second quarter 2025 financial results after the market closes on August 14, 2025. A conference call and webcast will follow at 5:00 p.m. Eastern Time, allowing investors to engage with the company's management. Elutia focuses on drug-eluting biomatrix technologies, aiming to enhance the compatibility of medical devices for patients.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia is scheduled to release its financial results, indicating transparency.
  • The company is involved in innovative drug-eluting biomatrix technologies which may have a positive market impact.
  • The rise in the need for implantable technologies positions Elutia favorably within the healthcare sector.

Full Press Release Details

GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its second quarter 2025 financial results after market close on Thursday, August 14, 2025. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13754773
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.

Frequently Asked Questions

When will Elutia announce its Q2 financial results?

Elutia will release its Q2 financial results on August 14, 2025.

What time is Elutia's conference call on August 14, 2025?

The conference call begins at 5:00 p.m. Eastern Time.

How can I access Elutia's conference call?

Call 877-407-8029 for U.S. investors and 201-689-8029 for international investors.

Where can I find Elutia's webcast after the conference?

The webcast will be available in the 'Investors' section on Elutia's website.

What is Elutia's mission?

Elutia aims to humanize medicine for patients needing implantable technologies.

Tags: ELUT Viatris Investor Conferences Healthcare Elutia financial results drug-eluting biomatrix biopharma investors
Last updated: Jul 31, 2025